Manifold Partners’s Cantel Medical Corporation CMD Stock Holding History

Manifold Partners’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,502	Closed	-$653K	–	40
2016 Q2	$653K	Sell	9,502 -475	-5%	-$32.8K	0.52%	28
2016 Q1	$712K	Buy	+9,977	New	+$626K	0.64%	31

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Manifold Partners's CMD Position: Q3 2016 in Review

Manifold Partners sold out of Cantel Medical Corporation (CMD) in Q3 2016, closing a stake of 9,502 shares — an estimated $653K sold.

Manifold Partners first reported a position in CMD in Q1 2016 and held it in 2 quarters. The position peaked at $712K in Q1 2016. 227 funds tracked by Wall St. Rank hold CMD as of Q3 2016.

Manifold Partners reported no remaining Cantel Medical Corporation position as of Q3 2016 after selling out during the quarter.
Manifold Partners sold 9,502 Cantel Medical Corporation shares in Q3 2016, an estimated $653K.
Manifold Partners first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 2 quarters.
Manifold Partners's Cantel Medical Corporation position peaked at $712K in Q1 2016.
227 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2016.

Based on Manifold Partners's 13F filing for Q3 2016, filed 8 Nov 2016.